首页> 外文期刊>Journal of infection and chemotherapy: official journal of the Japan Society of Chemotherapy >In vitro antifungal drug susceptibilities of Penicillium marneffei from China
【24h】

In vitro antifungal drug susceptibilities of Penicillium marneffei from China

机译:中国马尔尼菲青霉菌的体外抗真菌药敏性

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Penicillium marneffei infections in immunocompromised patients are often fatal, but early treatment with appropriate antifungal agents may have a good prognosis. To select drugs for treating P. marneffei infection in Southern China, the susceptibilities of antifungal agents against P. marneffei isolates were evaluated. Twenty-five strains of P. marneffei were isolated from patients from 2008 to 2010 in Guangxi Province of China, and 14 strains were isolated from bamboo rats. The activity of voriconazole, fluconazole, itraconazole, terbinafine, and amphotericin B on the isolates was assessed by MIC analysis. Voriconazole MIC against strains of P. marneffei ranged from 0.004 to 0.25 mg/l, and it had the lowest MIC (geometric mean values, 0.04 mg/l) in comparison to the other antifungal agents. The MICs of other antifungal agents, in order of lowest to highest, were as follows: itraconazole, terbinafine, amphotericin B, and fluconazole. The results show voriconazole and itraconazole are active against P. marneffei isolates in vitro, and terbinafine may have unrealized usefulness in the treatment of infections caused by this yeast form.
机译:免疫力低下患者的马尔尼菲青霉菌感染通常是致命的,但早期用适当的抗真菌药物治疗可能预后良好。为了选择治疗华南疟原虫感染的药物,评估了抗真菌剂对疟原虫分离株的敏感性。 2008年至2010年在中国广西省从患者中分离出25株马尔尼菲疟原虫,从竹鼠中分离出14株。通过MIC分析评估伏立康唑,氟康唑,伊曲康唑,特比萘芬和两性霉素B对分离物的活性。伏立康唑对马尔尼菲疟原虫菌株的MIC范围为0.004至0.25 mg / l,与其他抗真菌药相比,MIC最低(几何平均值0.04 mg / l)。其他抗真菌药的MIC值从高到低依次为:伊曲康唑,特比萘芬,两性霉素B和氟康唑。结果表明伏立康唑和伊曲康唑在体外对马尔尼菲假单胞菌具有活性,特比萘芬在治疗由这种酵母形式引起的感染中可能没有实现的效用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号